LAKE OSWEGO, Ore., Dec. 19, 2025 /PRNewswire/ -- Soin Neuroscience and BIOTRONIK Neuro today announced a research collaboration to advance personalized spinal cord stimulation (SCS) tuning using Soin ...
Boosting communication between the spinal nerves and the muscles using the spinal cord stimulation reverses spinal muscle atrophy (SMA) progression and could be applied to other motoneuron diseases, ...
The US Food and Drug Administration (FDA) has granted breakthrough device designation to the Avantis spinal cord stimulation system (Reach Neuro, Inc), which has been shown in early testing to restore ...
"We are pleased to collaborate with Soin Neuroscience on this important research initiative," said Todd Langevin, President at BIOTRONIK Neuro. "This work reflects our continued commitment to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback